FSH Aggravates Periodontitis-related Bone Loss in Ovariectomized Rats

Abstract

Alveolar bone loss is one of the prominent pathologic and clinical features of periodontitis. Recently, the direct effect of follicle-stimulating hormone (FSH) on bone resorption has been demonstrated. However, the effect of FSH on alveolar bone loss remains unknown. This study tested the hypothesis that FSH would exacerbate periodontitis-related alveolar bone loss. Experimental periodontitis was induced in ovariectomized rats, and the rats were treated with extrinsic FSH or its inhibitor, leuprorelin. After mandibles were collected, we performed morphological examinations to evaluate bone loss, enzyme histochemical tests for osteoclasts, and immunohistochemical examinations for FSH receptor (FSHR). The results showed that FSH significantly increased alveolar bone resorption compared with non-FSH-treated ovariectomized rats (P < 0.05), and the number of FSHR-positive cells was positively correlated with alveolar bone loss area (r = 0.682, P < 0.01). Our results suggested that FSH can aggravate alveolar bone loss by FSHR, independent of estrogen.

Get full access to this article

View all access options for this article.

References

Abouelfadel Z, Crawford ED (2008). Leuprorelin depot injection: patient considerations in the management of prostatic cancer. Ther Clin Risk Manag 4:513–526.

Cai X, Li C, Du G, Cao Z (2008). Protective effects of baicalin on ligature-induced periodontitis in rats. J Periodontal Res 43:14–21.

Chrisp P, Sorkin EM (1991). Leuprorelin: a review of its pharmacology and therapeutic use in prostatic disorders. Drugs Aging 1:487–509.

Crawford JM, Taubman MA, Smith DJ (1978). The natural history of periodontal bone loss in germfree and gnotobiotic rats infected with periodontopathic microorganisms. J Periodontal Res 13:316–325.

Di Paola R, Marzocco S, Mazzon E, Dattola F, Rotondo F, Britti D, et al. (2004). Effect of aminoguanidine in ligature-induced periodontitis in rats. J Dent Res 83:343–348.

Duarte PM, de Assis DR, Casati MZ, Sallum AW, Sallum EA, Nociti FH Jr (2004). Alendronate may protect against increased periodontitis-related bone loss in estrogen-deficient rats. J Periodontol 75:1196–1202.

Duarte PM, Gonçalves PF, Casati MZ, de Toledo S, Sallum EA, Nociti FH Jr (2006). Estrogen and alendronate therapies may prevent the influence of estrogen deficiency on the tooth-supporting alveolar bone: a histometric study in rats. J Periodontal Res 41:541–546.

Ejiri S, Toyooka E, Tanaka M, Anwar RB, Kohno S (2006). Histological and histomorphometrical changes in rat alveolar bone following antagonistic tooth extraction and/or ovariectomy. Arch Oral Biol 51:941–950.

Gilles JA, Carnes DL, Dallas MR, Holt SC, Bonewald LF (1997). Oral bone loss is increased in ovariectomized rats. J Endod 23:419–422.

10.

Graves DT, Cochran D (2003). The contribution of interleukin-1 and tumor necrosis factor to periodontal tissue destruction. J Periodontol 74:391–401.

11.

Iqbal J, Sun L, Kumar R, Blair C, Zaidi M (2006). Follicle-stimulating hormone stimulates TNF production from immune cells to enhance osteoblast and osteoclast formation. Proc Natl Acad Sci USA 103:14925–14930.

12.

Kawamoto S, Nagaoka E (2000). The effect of oestrogen deficiency on the alveolar bone resorption caused by traumatic occlusion. J Oral Rehabil 27:587–594.

13.

Kawamoto S, Ejiri S, Nagaoka E, Ozawa H (2002). Effects of oestrogen deficiency on osteoclastogenesis in the rat periodontium. Arch Oral Biol 47:67–73.

14.

Liu R, Bal HS, Desta T, Krothapalli N, Alyassi M, Luan Q, et al. (2006). Diabetes enhances periodontal bone loss through enhanced resorption and diminished bone formation. J Dent Res 85:510–514.

15.

Löe H (1993). Periodontal disease. The sixth complication of diabetes mellitus. Diabetes Care 16:329–334.

16.

Martin TJ, Gaddy D (2006). Bone loss goes beyond estrogen. Nat Med 12:612–613.

17.

Minkin C (1982). Bone acid phosphatase: tartrate-resistant acid phosphatase as a marker of osteoclast function. Calcif Tissue Int 34:285–290.

18.

Socransky SS, Haffajee AD, Cugini MA, Smith C, Kent RJ Jr (1998). Microbial complexes in subgingival plaque. J Clin Periodontol 25: 134–144.

19.

Sun L, Peng Y, Sharrow AC, Iqbal J, Zhang Z, Papachristou DJ, et al. (2006). FSH directly regulates bone mass. Cell 125:247–260.

20.

Tanaka M, Ejiri S, Toyooka E, Kohno S, Ozawa H (2002). Effects of ovariectomy on trabecular structures of rat alveolar bone. J Periodontal Res 37:161–165.

21.

Tanaka M, Toyooka E, Kohno S, Ozawa H, Ejiri S (2003). Long-term changes in trabecular structure of aged rat alveolar bone after ovariectomy. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 95:495–502.

22.

Yamashiro T, Takano-Yamamoto T (2001). Influences of ovariectomy of experimental tooth movement in the rat. J Dent Res 80:1858–1861.

23.

Zaidi M, Blair HC, Iqbal J, Zhu LL, Kumar TR, Zallone A, et al. (2007). Proresorption actions of FSH and bone loss. Ann NY Acad Sci 1116:376–382.

24.

Zhang J, Peng B, Chen X (2005). Expressions of nuclear factor κB, inducible nitric oxide synthase, and vascular endothelial growth factor in adenoid cystic carcinoma of salivary glands: Correlations with the angiogenesis and clinical outcome. Clin Cancer Res 11: 7334–7343.